664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis. - Valero-Arrese, L.; Doz, F.; Nysom, K.; Sjöberg Bexelius, T.; Idbaih, A.; Geoerger, B.; Kebudi, R.; Burcoveanu, D-I.; Neu, N.; Brega, N.; Drilon, A.; Laetsch, T.W.; et al. (Annals of Oncology, 2025)